Tool helps states measure low-value care
SHELBY LIVINGSTON June 01, 2019 01:00 AM
The first step on the journey to eliminating
low-value care is measuring it.
Several initiatives, from Choosing Wisely to the
Task Force on Low-Value Care to the U.S. Preventive Services Task Force, have
created lists of tests and procedures considered to have little to no clinical
benefit.
But turning those lists into measures that can
be identified in claims data is no easy feat. An inappropriate test for one
patient may be necessary for another, and insurance claims often lack details
needed to tell the difference.
The Virginia Center on Health Innovation and the
Washington Health Alliance analyze data from their states’ all-payer claims
databases using a health waste calculator sold by Milliman under the MedInsight
name.
The tool, which was developed in collaboration
with VBID Health, focuses on measures that are prevalent, have simple
definitions and lack controversy, according to Marcos Dachary, director of
MedInsight product management for Milliman. It also picks measures that
organizations could feasibly do something about.
The tool, which tracks 47 different tests and
procedures that reflect 85 Choosing Wisely measures, can comb through millions
of lines of claims to pinpoint care that is potentially wasteful.
On a post-adjudicated claims basis, the tool
identifies the age of the patient, diagnosis and services provided to allow
organizations to see what types of low-value care are most prevalent among the
population. Often, those are services that don’t cost much but occur
frequently.
A 2017 Health Affairs study found that of the 1.7
million low-value healthcare services Virginians received in 2014, 93% were low
or very low cost, or $538 per service or less. Those largely included lab tests
and medications. Just 7% were high or very high cost, or $539 or more. Those
included imaging tests
and procedures.
Virginia spent $381 million on the low and very
low cost services that year, which was nearly twice as much as it spent on the
high to very high cost services. In total, it spent more than $586 million on
low-value care in 2014, or 2.1% of total statewide healthcare costs. That’s a
conservative estimate though; the study looked at only 44 low-value care
measures.
Meanwhile, the Washington Health Alliance’s
December 2018 report showed that for about 2 million commercially insured and
Medicaid patients, $341 million was spent on 48 measures of unnecessary
healthcare from mid-2016 to mid-2017.
The study found that 92% of all wasteful
services analyzed were either low or very low cost. The top three drivers were
opioid medications for lower back pain in the first four weeks, antibiotics for
upper respiratory and ear infections, and annual EKGs or cardiac screening for
low-risk patients.
Beyond Virginia and Washington, Dachary said
Milliman is processing data for Maine and Colorado. It is also slated to
publish a report with RAND Corp. on wasteful spending among Medicare
beneficiaries.
No comments:
Post a Comment